These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 32948566)

  • 1. Epidemiological evidence for a hereditary contribution to myasthenia gravis: a retrospective cohort study of patients from North America.
    Green JD; Barohn RJ; Bartoccion E; Benatar M; Blackmore D; Chaudhry V; Chopra M; Corse A; Dimachkie MM; Evoli A; Florence J; Freimer M; Howard JF; Jiwa T; Kaminski HJ; Kissel JT; Koopman WJ; Lipscomb B; Maestri M; Marino M; Massey JM; McVey A; Mezei MM; Muppidi S; Nicolle MW; Oger J; Pascuzzi RM; Pasnoor M; Pestronk A; Provenzano C; Ricciardi R; Richman DP; Rowin J; Sanders DB; Siddiqi Z; Soloway A; Wolfe GI; Wulf C; Drachman DB; Traynor BJ
    BMJ Open; 2020 Sep; 10(9):e037909. PubMed ID: 32948566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Utility of Acetylcholine Receptor Antibody Testing in Ocular Myasthenia Gravis.
    Peeler CE; De Lott LB; Nagia L; Lemos J; Eggenberger ER; Cornblath WT
    JAMA Neurol; 2015 Oct; 72(10):1170-4. PubMed ID: 26258604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of anti-acetylcholine receptor antibody levels and long-term outcomes of juvenile myasthenia gravis in Taiwan: a case control study.
    Chou CC; Su IC; Chou IJ; Lin JJ; Lan SY; Wang YS; Kong SS; Chen YJ; Hsieh MY; Hung PC; Wang HS; Chou ML; Lin KL;
    BMC Neurol; 2019 Jul; 19(1):170. PubMed ID: 31319795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of the prevalence of familial autoimmune myasthenia gravis in a Spanish cohort.
    Salvado M; Canela M; Ponseti JM; Lorenzo L; Garcia C; Cazorla S; Gili G; Raguer N; Gamez J
    J Neurol Sci; 2016 Jan; 360():110-4. PubMed ID: 26723985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adult onset acquired myasthenia gravis in three Great Dane littermates.
    Kent M; Glass EN; Acierno M; Shelton GD
    J Small Anim Pract; 2008 Dec; 49(12):647-50. PubMed ID: 18684140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuromuscular junction autoimmune disease: muscle specific kinase antibodies and treatments for myasthenia gravis.
    Vincent A; Leite MI
    Curr Opin Neurol; 2005 Oct; 18(5):519-25. PubMed ID: 16155434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of anti-acetylcholine receptor profiles between Chinese cases of adult- and juvenile-onset myasthenia gravis using cell-based assays.
    Yan C; Zhao R; Song J; Feng X; Xi J; Luo S; Zhong H; Zhou S; Li W; Zhao C
    J Neuroimmunol; 2020 Dec; 349():577403. PubMed ID: 32992216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disorders affecting the acetylcholine receptor: myasthenia gravis and congenital myasthenia.
    Vincent A
    J Recept Res; 1987; 7(1-4):599-616. PubMed ID: 2442386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence of underdiagnosis of myasthenia gravis in older people.
    Vincent A; Clover L; Buckley C; Grimley Evans J; Rothwell PM;
    J Neurol Neurosurg Psychiatry; 2003 Aug; 74(8):1105-8. PubMed ID: 12876244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial autoimmune myasthenia gravis with different pathogenetic antibodies.
    Provenzano C; Arancio O; Evoli A; Rocca B; Bartoccioni E; de Grandis D; Tonali P
    J Neurol Neurosurg Psychiatry; 1988 Sep; 51(9):1228-30. PubMed ID: 3225607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetics of autoimmune myasthenia gravis, a model for antibody-mediated autoimmunity in man.
    Garchon HJ
    J Autoimmun; 2003 Sep; 21(2):105-10. PubMed ID: 12935778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquired myasthenia gravis in childhood.
    Evoli A
    Curr Opin Neurol; 2010 Oct; 23(5):536-40. PubMed ID: 20581680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study.
    Howard JF; Utsugisawa K; Benatar M; Murai H; Barohn RJ; Illa I; Jacob S; Vissing J; Burns TM; Kissel JT; Muppidi S; Nowak RJ; O'Brien F; Wang JJ; Mantegazza R;
    Lancet Neurol; 2017 Dec; 16(12):976-986. PubMed ID: 29066163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A genome-wide association study of myasthenia gravis.
    Renton AE; Pliner HA; Provenzano C; Evoli A; Ricciardi R; Nalls MA; Marangi G; Abramzon Y; Arepalli S; Chong S; Hernandez DG; Johnson JO; Bartoccioni E; Scuderi F; Maestri M; Gibbs JR; Errichiello E; Chiò A; Restagno G; Sabatelli M; Macek M; Scholz SW; Corse A; Chaudhry V; Benatar M; Barohn RJ; McVey A; Pasnoor M; Dimachkie MM; Rowin J; Kissel J; Freimer M; Kaminski HJ; Sanders DB; Lipscomb B; Massey JM; Chopra M; Howard JF; Koopman WJ; Nicolle MW; Pascuzzi RM; Pestronk A; Wulf C; Florence J; Blackmore D; Soloway A; Siddiqi Z; Muppidi S; Wolfe G; Richman D; Mezei MM; Jiwa T; Oger J; Drachman DB; Traynor BJ
    JAMA Neurol; 2015 Apr; 72(4):396-404. PubMed ID: 25643325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myasthenia gravis, a model of organ-specific autoimmune disease.
    Berrih-Aknin S
    J Autoimmun; 1995 Apr; 8(2):139-43. PubMed ID: 7612144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of genetic risk loci and prioritization of genes and pathways for myasthenia gravis: a genome-wide association study.
    Chia R; Saez-Atienzar S; Murphy N; Chiò A; Blauwendraat C; ; Roda RH; Tienari PJ; Kaminski HJ; Ricciardi R; Guida M; De Rosa A; Petrucci L; Evoli A; Provenzano C; Drachman DB; Traynor BJ
    Proc Natl Acad Sci U S A; 2022 Feb; 119(5):. PubMed ID: 35074870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myasthenia gravis and the neuromuscular junction.
    Querol L; Illa I
    Curr Opin Neurol; 2013 Oct; 26(5):459-65. PubMed ID: 23945282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pseudo-internuclear ophthalmoplegia in myasthenia gravis].
    Bogdan I; Crisanda V
    Oftalmologia; 2011; 55(3):70-3. PubMed ID: 22428294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early-onset myasthenia gravis.
    Roach ES; Buono G; McLean WT; Weaver RG
    J Pediatr; 1986 Feb; 108(2):193-7. PubMed ID: 3944702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Characteristics of Patients With Double-Seronegative Myasthenia Gravis and Antibodies to Cortactin.
    Cortés-Vicente E; Gallardo E; Martínez MÁ; Díaz-Manera J; Querol L; Rojas-García R; Illa I
    JAMA Neurol; 2016 Sep; 73(9):1099-104. PubMed ID: 27379450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.